Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid - PubMed (original) (raw)
Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid
Eileen F O'Shea et al. Int J Food Microbiol. 2012.
Abstract
The mechanisms by which intestinal bacteria achieve their associated health benefits can be complex and multifaceted. In this respect, the diverse microbial composition of the human gastrointestinal tract (GIT) provides an almost unlimited potential source of bioactive substances (pharmabiotics) which can directly or indirectly affect human health. Bacteriocins and fatty acids are just two examples of pharmabiotic substances which may contribute to probiotic functionality within the mammalian GIT. Bacteriocin production is believed to confer producing strains with a competitive advantage within complex microbial environments as a consequence of their associated antimicrobial activity. This has the potential to enable the establishment and prevalence of producing strains as well as directly inhibiting pathogens within the GIT. Consequently, these antimicrobial peptides and the associated intestinal producing strains may be exploited to beneficially influence microbial populations. Intestinal bacteria are also known to produce a diverse array of health-promoting fatty acids. Indeed, certain strains of intestinal bifidobacteria have been shown to produce conjugated linoleic acid (CLA), a fatty acid which has been associated with a variety of systemic health-promoting effects. Recently, the ability to modulate the fatty acid composition of the liver and adipose tissue of the host upon oral administration of CLA-producing bifidobacteria and lactobacilli was demonstrated in a murine model. Importantly, this implies a potential therapeutic role for probiotics in the treatment of certain metabolic and immunoinflammatory disorders. Such examples serve to highlight the potential contribution of pharmabiotic production to probiotic functionality in relation to human health maintenance.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
- Metabolic activities and probiotic potential of bifidobacteria.
Russell DA, Ross RP, Fitzgerald GF, Stanton C. Russell DA, et al. Int J Food Microbiol. 2011 Sep 1;149(1):88-105. doi: 10.1016/j.ijfoodmicro.2011.06.003. Epub 2011 Jun 24. Int J Food Microbiol. 2011. PMID: 21763022 Review. - Recombinant lactobacilli expressing linoleic acid isomerase can modulate the fatty acid composition of host adipose tissue in mice.
Rosberg-Cody E, Stanton C, O'Mahony L, Wall R, Shanahan F, Quigley EM, Fitzgerald GF, Ross RP. Rosberg-Cody E, et al. Microbiology (Reading). 2011 Feb;157(Pt 2):609-615. doi: 10.1099/mic.0.043406-0. Epub 2010 Dec 22. Microbiology (Reading). 2011. PMID: 21178166 - Lactobacillus salivarius: bacteriocin and probiotic activity.
Messaoudi S, Manai M, Kergourlay G, Prévost H, Connil N, Chobert JM, Dousset X. Messaoudi S, et al. Food Microbiol. 2013 Dec;36(2):296-304. doi: 10.1016/j.fm.2013.05.010. Epub 2013 Jun 15. Food Microbiol. 2013. PMID: 24010610 Review. - Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species.
Coakley M, Ross RP, Nordgren M, Fitzgerald G, Devery R, Stanton C. Coakley M, et al. J Appl Microbiol. 2003;94(1):138-45. doi: 10.1046/j.1365-2672.2003.01814.x. J Appl Microbiol. 2003. PMID: 12492934 - Fatty acid profile, trans-octadecenoic, α-linolenic and conjugated linoleic acid contents differing in certified organic and conventional probiotic fermented milks.
Florence AC, Béal C, Silva RC, Bogsan CS, Pilleggi AL, Gioielli LA, Oliveira MN. Florence AC, et al. Food Chem. 2012 Dec 15;135(4):2207-14. doi: 10.1016/j.foodchem.2012.07.026. Epub 2012 Jul 15. Food Chem. 2012. PMID: 22980792
Cited by
- Gut instinct: harnessing the power of probiotics to tame pathogenic signaling pathways in ulcerative colitis.
Hsu CY, Mustafa MA, Moath Omar T, Taher SG, Ubaid M, Gilmanova NS, Nasrat Abdulraheem M, Saadh MJ, Athab AH, Mirzaei R, Karampoor S. Hsu CY, et al. Front Med (Lausanne). 2024 Sep 11;11:1396789. doi: 10.3389/fmed.2024.1396789. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39323474 Free PMC article. Review. - Antimicrobial resistance: use of phage therapy in the management of resistant infections.
Ikpe F, Williams T, Orok E, Ikpe A. Ikpe F, et al. Mol Biol Rep. 2024 Aug 21;51(1):925. doi: 10.1007/s11033-024-09870-2. Mol Biol Rep. 2024. PMID: 39167154 Review. - Transcriptome and metabolome analysis reveals PRV XJ delgE/gI/TK protects intracranially infected mice from death by regulating the inflammation.
Xu L, Zhang Y, Tao Q, Xu T, Lee FQ, Deng LS, Jian Z, Zhao J, Yang Y, Lai S, Zhou YC, Xu ZW, Zhu L. Xu L, et al. Front Microbiol. 2024 Mar 14;15:1374646. doi: 10.3389/fmicb.2024.1374646. eCollection 2024. Front Microbiol. 2024. PMID: 38550870 Free PMC article. - Antibiotics and probiotics-induced effects on the total fatty acid composition of feces in a rat model.
Marosvölgyi T, Mintál K, Farkas N, Sipos Z, Makszin L, Szabó É, Tóth A, Kocsis B, Kovács K, Hormay E, Lénárd L, Karádi Z, Bufa A. Marosvölgyi T, et al. Sci Rep. 2024 Mar 19;14(1):6542. doi: 10.1038/s41598-024-57046-6. Sci Rep. 2024. PMID: 38503819 Free PMC article. - The strain-dependent cytostatic activity of Lactococcus lactis on CRC cell lines is mediated through the release of arginine deiminase.
Jastrząb R, Tomecki R, Jurkiewicz A, Graczyk D, Szczepankowska AK, Mytych J, Wolman D, Siedlecki P. Jastrząb R, et al. Microb Cell Fact. 2024 Mar 14;23(1):82. doi: 10.1186/s12934-024-02345-w. Microb Cell Fact. 2024. PMID: 38481270 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources